Avid Bioservices Inc (CDMO)

[dia76ca]

Will there be Bavi/anti-PD-1 data released January 30? The summary of the Jan.30 presentation includes the following...

" Using multiple tumor models in mice, we demonstrate PS targeting antibodies enhance the anti-tumor activity of multiple forms of therapy including anti-CTLA-4 and anti-PD-1 checkpoint inhibitor antibodies."

We have already seen some of the data from the Bavi/Yervoy combination. However we have not yet seen any Bavi/anti-PD-1 data. This should be interesting.